Dosage Forms Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dosage Forms stocks.

Dosage Forms Stocks Recent News

Date Stock Title
Apr 22 NVS Top Analyst Reports for Novartis, American Express & ConocoPhillips
Apr 22 NVS Novartis Q1 2024 Earnings Preview
Apr 22 ATR SNAP Gears Up to Report Q1 Earnings: What's in the Cards?
Apr 22 ATR Is a Beat in Store for A. O. Smith (AOS) in Q1 Earnings?
Apr 21 NVS Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 19 ATR Will Increasing Expenses Dent IDEX's (IEX) Q1 Earnings?
Apr 19 NVS Novartis Looks To Get Back On Track With Q1 Earnings
Apr 19 ATR Lam Research (LRCX) to Post Q3 Earnings: What's in the Cards?
Apr 19 NVS Novartis (NVS) to Report Q1 Earnings: What to Expect?
Apr 19 ATR AptarGroup, Inc. (NYSE:ATR) Passed Our Checks, And It's About To Pay A US$0.41 Dividend
Apr 19 NVS FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk
Apr 18 NVS US FDA mandates label updates on CAR-T cancer therapies
Apr 18 ATR What's in Store for Texas Instruments (TXN) in Q1 Earnings?
Apr 18 ATR Danaher (DHR) Gears Up to Post Q1 Earnings: Is a Beat Likely?
Apr 18 NVS Exploring Analyst Estimates for Novartis (NVS) Q1 Earnings, Beyond Revenue and EPS
Apr 18 NXGL NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024
Apr 17 NVS 2 High-Yield Dividend Stocks to Buy and Hold for 10 Years
Apr 17 ATR Zacks.com featured highlights Freshpet, AptarGroup, Montrose Environmental, Greenbrier and PDD
Apr 17 NVS Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Apr 16 ARCT As more rare disease therapies launch, their prices are rising
Dosage Forms

Browse All Tags